Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 8, 2015, Pages 776-784

  Iwakura, N ^a   Fujiwara, Y ^a   Tanaka, F ^a   Tanigawa, T ^a   Yamagami, H ^a   Shiba, M ^a   Tominaga, K ^a   Watanabe, T ^a   Iijima, K ^b   Koike, T ^b   Walls, A F ^c   Arakawa, T ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BB1 ANTIBODY; FLUTICASONE; PROTON PUMP INHIBITOR; THYMIC STROMAL LYMPHOPOIETIN; TRYPTASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASOPHIL; CELL COUNT; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; ENDOSCOPY; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGEAL EOSINOPHILIA; ESOPHAGUS; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTON PUMP INHIBITOR RESPONSIVE ESOPHAGEAL EOSINOPHILIA; QUANTITATIVE ANALYSIS; TREATMENT DURATION; TREATMENT RESPONSE; AGED; ESOPHAGOSCOPY; INTESTINE MUCOSA; LEUKOCYTE COUNT; METABOLISM; MIDDLE AGED;

ADULT; AGED; BASOPHILS; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS;

EID: 84925135280     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13141     Document Type: Article

References (32)

1. Liacouras CA, Furuta GT, Hirano I, et al,. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3-20.
2. Dellon ES, Gonsalves N, Hirano I, et al,. ACG clinical guideline: evidence based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis. Am J Gastroenterol 2013; 108: 679-92.
3. Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al,. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 2011; 9: 110-7.
4. Abe Y, Iijima K, Ohara S, et al,. A Japanese case series of 12 patients with esophageal eosinophilia. J Gastroenterol 2011; 46: 25-30.
5. Francis DL, Foxx-Orenstein A, Arora AS, et al,. Results of ambulatory pH monitoring do not reliably predict response to therapy in patients with eosinophilic oesophagitis. Aliment Pharmacol Ther 2012; 35: 300-7.
6. Fujiwara Y, Sugawa T, Tanaka F, et al,. A multicenter study on the prevalence of eosinophilic esophagitis and PPI-responsive esophageal eosinophilic infiltration. Intern Med 2012; 51: 3235-9.
7. Peterson KA, Thomas KL, Hilden K, et al,. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 2010; 55: 1313-9.
8. Moawad FJ, Veerappan GR, Dias JA, et al,. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol 2013; 108: 366-72.
9. Dellon ES, Speck O, Woodward K, et al,. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 2013; 108: 1854-60.
10. Ishizaka T, De Bernardo R, Tomioka H, Lichtenstein LM, Ishizaka K,. Identification of basophil granulocytes as a site of allergic histamine release. J Immunol 1972; 108: 1000-8.
11. Schroeder JT,. Basophils beyond effector cells of allergic inflammation. Adv Immunol 2009; 101: 123-61.
12. Siracusa MC, Kim BS, Spergel JM, Artis D,. Basophils and allergic inflammation. J Allergy Clin Immunol 2013; 132: 789-801.
13. Schroeder JT,. Basophils: emerging roles in the pathogenesis of allergic disease. Immunol Rev 2011; 242: 144-60.
14. Noti M, Wojno ED, Kim BS, et al,. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med 2013; 19: 1005-13.
15. Lundell LR, Dent J, Bennett JR, et al,. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
16. Agis H, Krauth MT, Bohm A, et al,. Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders. Am J Clin Pathol 2006; 125: 273-81.
17. Ito Y, Satoh T, Takayama K, et al,. Basophil recruitment and activation in inflammatory skin diseases. Allergy 2011; 66: 1107-13.
18. Moawad FJ, Schoepfer AM, Safroneeva E, et al,. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings. Aliment Pharmacol Ther 2014; 39: 603-8.
19. Molina-Infante J, Rivas MD, Hernandez-Alonso M, et al,. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression. Aliment Pharmacol Ther 2014; 40: 955-65.
20. Dellon ES, Speck O, Woodward K, et al,. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol 2014; 12: 2015-22.
21. Wen T, Dellon ES, Moawad FJ, et al,. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol 2015; 135: 187-97.
22. Spechler SJ, Genta RM, Souza RF,. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007; 102: 1301-6.
23. van Rhijn BD, Weijenborg PW, Verheij J, et al,. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol 2014; 12: 1815-23.
24. Katzka DA, Tadi R, Smyrk TC, et al,. Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2014; 12: 1824-9.
25. Cheng E, Zhang X, Huo X, et al,. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 2013; 62: 824-32.
26. Zhang X, Cheng E, Huo X, et al,. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS ONE 2012; 7: e50037.
27. Clayton F, Fang JC, Gleich GJ, et al,. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology 2014; 147: 602-9.
28. Rothenberg ME, Spergel JM, Sherrill JD, et al,. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 2010; 42: 289-91.
29. Sherrill JD, Gao PS, Stucke EM, et al,. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 2010; 126: 160-5.
30. Fujishiro H, Amano Y, Kushiyama Y, et al,. Eosinophilic esophagitis investigated by upper gastrointestinal endoscopy in Japanese patients. J Gastroenterol 2011; 46: 1142-4.
31. Suzuki H, Hibi T, Marshall BJ,. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007; 42: 1-15.
32. Dellon ES, Peery AF, Shaheen NJ, et al,. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology 2011; 141: 1586-92.